Lambros, Ashley M.
Sagar, Kelly A.
Dahlgren, M. Kathryn
Kosereisoglu, Deniz
El-Abboud, Celine
Smith, Rosemary T.
Gruber, Staci A.
Funding for this research was provided by:
Private donations
Article History
Received: 27 October 2022
Accepted: 31 March 2023
First Online: 11 April 2023
Competing interests
: The authors declare the following competing interests: S.A.G. reported grants from the National Institute on Drug Abuse, the Center for Medical Cannabis Research (CMCR), Foria/Praxis Ventures, and Charlotte's Web for projects outside the submitted work. Over the last five years, S.A.G. has reported receiving fees from the Coalition for Cannabis Policy, Education, and Regulation (CPEAR), Beth Israel Deaconess, Fenway Health, Greenwich Biosciences Cannabis Education Working Group, National Academy of Neuropsychology, McMaster University, Harvard Health Publications, University of Florida, and the Massachusetts College of Pharmacy and Health Sciences, all related to presentations outside the submitted work. S.A.G. is also a scientific advisor for Ajna Biosciences. M.K.D. reported receiving the McLean Hospital Jonathan Edward Brooking Mental Health Research Fellowship outside the submitted work. K.A.S. reported receiving the McLean Hospital Eleanor and Miles Shore Fellowship and the Charles Robert Broderick III Phytocannabinoid Research Fellowship, and reported receiving fees from CPEAR outside the submitted work. All other authors have no competing interests to declare. No funding sources were involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.